227 related articles for article (PubMed ID: 16928786)
21. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics of fexofenadine: evaluation of a microdose and assessment of absolute oral bioavailability.
Lappin G; Shishikura Y; Jochemsen R; Weaver RJ; Gesson C; Houston B; Oosterhuis B; Bjerrum OJ; Rowland M; Garner C
Eur J Pharm Sci; 2010 May; 40(2):125-31. PubMed ID: 20307657
[TBL] [Abstract][Full Text] [Related]
23. The different effects of itraconazole on the pharmacokinetics of fexofenadine enantiomers.
Tateishi T; Miura M; Suzuki T; Uno T
Br J Clin Pharmacol; 2008 May; 65(5):693-700. PubMed ID: 18294330
[TBL] [Abstract][Full Text] [Related]
24. Itraconazole greatly increases plasma concentrations and effects of felodipine.
Jalava KM; Olkkola KT; Neuvonen PJ
Clin Pharmacol Ther; 1997 Apr; 61(4):410-5. PubMed ID: 9129558
[TBL] [Abstract][Full Text] [Related]
25. The effect of ingestion time interval on the interaction between itraconazole and triazolam.
Neuvonen PJ; Varhe A; Olkkola KT
Clin Pharmacol Ther; 1996 Sep; 60(3):326-31. PubMed ID: 8841155
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using alfentanil and fexofenadine in combination.
Kharasch ED; Walker A; Hoffer C; Sheffels P
J Clin Pharmacol; 2005 Jan; 45(1):79-88. PubMed ID: 15601808
[TBL] [Abstract][Full Text] [Related]
27. The utility of mixed-effects covariate analysis in rapid selection of doses in pediatric subjects: a case study with fexofenadine hydrochloride.
Krishna R; Krishnaswami S; Kittner B; Sankoh AJ; Jensen BK
Biopharm Drug Dispos; 2004 Dec; 25(9):373-87. PubMed ID: 15517550
[TBL] [Abstract][Full Text] [Related]
28. Loratadine and terfenadine interaction with nefazodone: Both antihistamines are associated with QTc prolongation.
Abernethy DR; Barbey JT; Franc J; Brown KS; Feirrera I; Ford N; Salazar DE
Clin Pharmacol Ther; 2001 Mar; 69(3):96-103. PubMed ID: 11240972
[TBL] [Abstract][Full Text] [Related]
29. Short-term effect of quercetin on the pharmacokinetics of fexofenadine, a substrate of P-glycoprotein, in healthy volunteers.
Kim KA; Park PW; Park JY
Eur J Clin Pharmacol; 2009 Jun; 65(6):609-14. PubMed ID: 19221726
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of duloxetine hydrochloride enteric-coated tablets in healthy Chinese volunteers: a randomized, open-label, single- and multiple-dose study.
Zhao RK; Cheng G; Tang J; Song J; Peng WX
Clin Ther; 2009 May; 31(5):1022-36. PubMed ID: 19539103
[TBL] [Abstract][Full Text] [Related]
31. Probenecid, but not cystic fibrosis, alters the total and renal clearance of fexofenadine.
Liu S; Beringer PM; Hidayat L; Rao AP; Louie S; Burckart GJ; Shapiro B
J Clin Pharmacol; 2008 Aug; 48(8):957-65. PubMed ID: 18511651
[TBL] [Abstract][Full Text] [Related]
32. Modest effect of impaired P-glycoprotein on the plasma concentrations of fexofenadine, quinidine, and loperamide following oral administration in collies.
Kitamura Y; Koto H; Matsuura S; Kawabata T; Tsuchiya H; Kusuhara H; Tsujimoto H; Sugiyama Y
Drug Metab Dispos; 2008 May; 36(5):807-10. PubMed ID: 18299336
[TBL] [Abstract][Full Text] [Related]
33. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
[TBL] [Abstract][Full Text] [Related]
34. Effect of itraconazole on the pharmacokinetics of atenolol.
Lilja JJ; Backman JT; Neuvonen PJ
Basic Clin Pharmacol Toxicol; 2005 Dec; 97(6):395-8. PubMed ID: 16364056
[TBL] [Abstract][Full Text] [Related]
35. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
Darwish M; Chang S; Hellriegel ET
Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
[TBL] [Abstract][Full Text] [Related]
36. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography.
Tashiro M; Sakurada Y; Iwabuchi K; Mochizuki H; Kato M; Aoki M; Funaki Y; Itoh M; Iwata R; Wong DF; Yanai K
J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093
[TBL] [Abstract][Full Text] [Related]
37. Effect of oral ketoconazole on intestinal first-pass effect of midazolam and fexofenadine in cynomolgus monkeys.
Ogasawara A; Kume T; Kazama E
Drug Metab Dispos; 2007 Mar; 35(3):410-8. PubMed ID: 17142564
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
39. Relative contribution of absorptive and secretory transporters to the intestinal absorption of fexofenadine in rats.
Ujie K; Oda M; Kobayashi M; Saitoh H
Int J Pharm; 2008 Sep; 361(1-2):7-11. PubMed ID: 18572335
[TBL] [Abstract][Full Text] [Related]
40. Itraconazole increases but grapefruit juice greatly decreases plasma concentrations of celiprolol.
Lilja JJ; Backman JT; Laitila J; Luurila H; Neuvonen PJ
Clin Pharmacol Ther; 2003 Mar; 73(3):192-8. PubMed ID: 12621384
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
